Document:

EXHIBIT 4.1

Mr. Ron Reddick                              March 22, 2000
5085 Lift Drive, Suite 201
Colorado Springs, CO  80919

Dear Ron:

Position Offered: We are very pleased to offer you the position of Executive
Vice President, Director of Sales and Marketing for Oleramma, Inc.  You will
become an Officer of the Company.

Signing Bonus: You will also be entitled to receive a signing bonus of 120,000
Shares ("Bonus Shares") . These Bonus Shares will  issued in the amount of
10,000 Bonus Shares per month commencing on the April 30th, 2000 and continuing
for the next 11 months, issued on the last business day of each month.   If you
decide not to commence employment by the start date all Bonus Shares shall be
returned to Oleramma, Inc. forthwith.

Termination:  Oleramma Inc.  agrees to pay you a separation allowance of three
month's base salary if you are terminated by Oleramma Inc., for any reason,
other than for just cause.  You will be entitled to keep all Bonus Shares
earned up to the point of Termination including the Bonus Shares due for the
current month that said termination takes place.  Furthermore, at the point of
Termination this agreement and all future Bonus Shares as well as this
agreement will be canceled.

If you are terminated by Oleramma, Inc. for just cause (which shall include
unsatisfactory performance as may be reasonably determined by the Board of
Directors) you will not be entitled to a separation allowance, however you will
keep all Bonus Shares earned through the end of the current month in which you
are terminated.

If you voluntarily terminate (resign) your employment agreement for any reason
you will not be entitled to the separation allowance listed above, however you
would retain all Bonus Shares earned though the end of the current month that
such termination (resignation ) was tendered.

Non-Disclosure: You will be required to sign a nondisclosure agreement.

Full-Time Position: You will be required to devote your services full-time to
Oleramma and agree to limit outside business activities to nonactive, passive
investments. Examples of these activities include management of employee's
personal financial assets such as financial instruments or real estate, either
directly or through closely held business entities.  Direct roles in outside
businesses must be pre-approved by the Board of Directors on an individual
basis.

Start Date: Your proposed start date with Oleramma is  April 1, 2000 or
earlier, and all documentation and financial transactions are to be completed
by then.

Entire Agreement:: This document fully includes or describes all principal
terms and conditions of your employment and there are no other representations
either verbal or otherwise.

We look forward to your acceptance of this offer, and welcome you as a key
member of the operational team at Oleramma, Inc.

Yours truly,

OLERAMMA, INC.

/s/ Larry Hunter
-----------------------
Larry Hunter, Director

/s/ Bry Behrmann
-----------------------
Bry Behrmann, Director

Please indicate your acceptance of this offer by signing below.

/s/ Ron Reddick
-----------------------------------
Ron Reddick    Date: March 22, 2000

<PAGE>EXHIBIT 4.2

Shane L. Weiskircher
3480 Jullion Way
Boise ID 83704

Dear Shane:

Position Offered:  We are very pleased to offer you the position of Vice
President, Internet Research for Oleramma, Inc.  You will become an Officer
of the Company.

Signing Bonus: You will also be entitled to receive a signing bonus of 60,000
Shares ("Bonus Shares") . These Bonus Shares will  issued in the amount of
5,000 Bonus Shares per month commencing on the April 1, 2000 and continuing
for the next 11 months on he 1st business day of each month.  If you decide
not to commence employment by the start date all Bonus Shares shall be
returned to Oleramma, Inc. forthwith.

Termination:  Oleramma, Inc. agrees to pay you a separation allowance of three
month's base salary if you are terminated by Oleramma, Inc., for any reason,
other than for just cause.  You will be entitled to keep all Bonus Shares
earned up to the point of Termination including the Bonus Shares due for the
current month that said termination takes place.  Furthermore, at the point of
Termination this agreement and all future Bonus Shares as well as this
agreement will be canceled.

If you are terminated by Oleramma, Inc. for just cause (which shall include
unsatisfactory performance as may be reasonably determined by the Board of
Directors) you will not be entitled to a separation allowance, however you will
keep all Bonus Shares earned through the end of the current month in which you
are terminated.

If you voluntarily terminate (resign) your employment agreement for any reason
you will not be entitled to the separation allowance listed above, however you
would retain all Bonus Shares earned though the end of the current month that
such termination (resignation ) was tendered.

Non-Disclosure: You will be required to sign a nondisclosure agreement.

Full-Time Position: You will be required to devote your services full-time to
Oleramma and agree to limit outside business activities to nonactive, passive
investments. Examples of these activities include management of employee's
personal financial assets such as financial instruments or real estate, either
directly or through closely held business entities.  Direct roles in outside
businesses must be pre-approved by the Board of Directors on an individual
basis.

Start Date: Your proposed start date with Oleramma is April 1, 2000 or earlier,
and all documentation and financial transactions are to be completed by then.

Entire Agreement:: This document fully includes or describes all principal
terms and conditions of your employment and there are no other representations
either verbal or otherwise.

We look forward to your acceptance of this offer, and welcome you as a key
member of the operational team at Oleramma, Inc.

Yours truly,

OLERAMMA, INC.

/s/ Larry Hunter
--------------------------
Larry Hunter, Director

/s/ Bry Behrmann
---------------------------
Bry Behrmann, Director

Please indicate your acceptance of this offer by signing below.

/s/ Shane L. Weiskircher
-----------------------------------------------
Shane L. Weiskircher       Date: March 22, 2000

<PAGE>EXHIBIT 4.3

CONSULTING AGREEMENT

This Agreement is made and entered into as of the 22nd day of March, 2000, by
and between Oleramma, Inc. ("Issuer") and the undersigned Dr. Lawrence Madoff,
M.D. ("Consultant").

                                 R E C I T A L S

A. WHEREAS, Issuer desires to retain Consultant, and Consultant desires to be
retained by Issuer, to provide consulting services to Issuer; and

B. WHEREAS, Issuer desires to compensate Consultant for Consultant's services
by issuing Shares of Issuer's common stock, and Consultant desires to be
compensated by the receipt of such Shares.

NOW, THEREFORE, in consideration of the mutual promises herein contained, the
parties agree as follows:

1. CONSULTING SERVICES AND COMPENSATION. On the terms and subject to the
conditions set forth in this agreement, Issuer and Consultant hereby agree that:

1.1 For a period of 180 days after the date of this agreement, Dr. Lawrence
Madoff, M.D,  who is a medical physician shall serve as a consultant to Issuer
and serve as a Guest Host, for the program "Ask the Doc," for the Issuer's
interactive Web Site, and to provide services within guidelines to be
established by Issuer from time to time (the "Consulting Services"); and

1.2 Issuer agrees to issue to Consultant and Consultant agrees to accept from
Issuer, as compensation for the Consulting Services, that number of Shares of
Issuer's common stock which is set forth on the Signature page of this
Agreement (the "Shares").

2. REGISTRATION, ISSUANCE AND DELIVERY OF SHARES. Issuer agrees to register the
issuance of the Shares to Consultant by filing a Form S-8 registration
statement (the "Registration  Statement") with the Securities and Exchange
Commission under the Securities Act of 1933, as amended (the "Securities Act").
Promptly after the Registration Statement becomes effective, Issuer shall issue
a stock certificate representing the Shares to Consultant and shall deliver the
stock certificate at the address specified by Consultant in the delivery
instructions on the signature page of this agreement.

3. ISSUER'S REPRESENTATIONS AND WARRANTIES. Issuer hereby represents and
warrants to Consultant that:

3.1  Authority. The individual executing and delivering this agreement on
Issuer's behalf has been duly authorized to do so, the signature of such
individual is binding upon Issuer, and Issuer is duly organized  and subsisting
under the laws of the jurisdiction in which it was organized.

3.2  Enforceability. Issuer has duly executed and delivered this agreement and
(subject to its execution by Consultant) it constitutes a valid and binding
agreement of Issuer enforceable in accordance with its terms against Issuer,
except as such enforceability may be limited by principles of public policy,
and subject to laws of general application relating to bankruptcy, insolvency
and the relief of debtors and rules of law governing specific performance,
injunctive relief or other equitable remedies.

3.3  Capitalization. Issuer has no outstanding capital stock other than common
stock as of the date of this agreement.  Issuer is authorized to issue
20,000,000 Shares of Common Stock, of which 6,767,200 Shares are issued
and outstanding.  All of Issuer's outstanding Shares of Common Stock have
been duly and validly issued and are fully paid, non-assessable and not
subject to any preemptive or similar rights; and the Shares have been duly
authorized and, when issued and delivered to Consultant as payment for
services rendered as provided by this agreement, will be validly issued,
fully paid and non-assessable, and the issuance of such Shares will not be
subject to any preemptive or similar rights.

4. MISCELLANEOUS.

4.1 Assignment. This Agreement is not Transferable or Assignable.

4.2 Execution and Delivery of Agreement. Each of the parties shall be entitled
to rely on delivery by facsimile transmission of an executed copy of this
agreement by the other party, and acceptance of such facsimile copies shall
create a valid and binding agreement between the parties.

4.3 Titles. The titles of the sections and subsections of this agreement are
for the convenience of reference only and are not to be considered in
construing this agreement.

4.4  Severability. The invalidity or unenforceability of any particular
provision of this agreement shall not affect or limit the validity or
enforceability of the remaining provisions of this agreement.

4.5  Entire  Agreement. This agreement constitutes the entire agreement and
understanding between the parties with respect to the subject matters herein
and supersedes and replaces any prior agreements and understandings, whether
oral or written, between them with respect to such matters.

4.6  Waiver and Amendment. Except as otherwise provided herein, the provisions
of this agreement may be waived, altered, amended or repealed, in whole or in
part, only upon the mutual written agreement of Consultant and Issuer.

4.7  Counterparts. This agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together
shall constitute one and the same instrument.

4.8  Governing Law.  This agreement is governed by and shall be construed in
accordance with the internal law of the State of Nevada without reference to
its rules as to conflicts of law.

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of
the date first above mentioned.

"ISSUER"

OLERAMMA, INC.

/s/ Richard Lindberg
-----------------------
Richard Lindberg

"CONSULTANT"

Dr. Lawrence Madoff, M.D.

/s/ Lawrence Madoff, M.D.
---------------------------
Signature

Dr. Lawrence Madoff, M.D
Vegas Medical Center
Polo Towers Plaza
3743 S. Las Vegas Blvd., Suite 107
Las Vegas NV 89109
702 892-8581

250,000 Shares
Number of Shares to be issued to Dr. Lawrence Madoff, M.D pursuant to this
Agreement.

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00005-of-00352.parquet"}]]